Initial Experience With Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETS) at a Tertiary Care United States Center

被引：0

作者：

Heckert, Jason ^{[1
]}

Botterbusch, Samuel ^{[2
]}

Kipnis, Sarit ^{[1
]}

Bennet, Bonita ^{[3
]}

Creamer, Caroline ^{[3
]}

Alderson, Alice ^{[3
]}

Eads, Jennifer ^{[3
]}

Soulen, Michael ^{[3
]}

Pryma, Daniel ^{[3
]}

Mankoff, David ^{[3
]}

Metz, David ^{[3
]}

Katona, Bryson ^{[3
]}

机构：

[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Univ Penn, Philadelphia, PA 19104 USA

[3] Perelman Sch Med, Philadelphia, PA USA

来源：

PANCREAS | 2020年 / 49卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：470 / 471

页数：2

共 50 条

[21] Prognostic value of systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
Teran Brage, E.
Reguera Puertas, P.
Campana-Diaz, E.
Navarro Martin, M.
Garcia Talavera, P.
Rama Alonso, S.
Lopez Gutierrez, A.
Roldan Ruiz, J.
Garijo Martinez, M. D. C.
Morchon Araujo, D.
Posado-Dominguez, L.
Redondo Gonzalez, J. C.
Diaz Sanchez, P.
Pablo Martin, E.
Felix, L. C.
Lozano Mejorada, R.
Fonseca Sanchez, E.
ANNALS OF ONCOLOGY, 2024, 35 : S758 - S759
[22] Real-world analysis of peptide receptor radionuclide therapy (PRRT) in the treatment of neuroendocrine tumors.
Chau, Justin
Yu, Nanmeng
Bakeri, Hirva
Menda, Yusuf
Dillon, Joseph S.
Chandrasekharan, Chandrikha
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23] Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: A NET Center of Excellence Experience
Grewal, Udhayvir S.
Loeffler, Bradley T.
Paschke, Alexander
Dillon, Joseph S.
Chandrasekharan, Chandrikha
JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1165 - 1170
[24] Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience
Sukrithan, Vineeth
Armbruster, Heather
Rogers, Sherise
Vogt, Sherry Mori
Grenade, Cassandra
Verschraegen, Claire
Zhou, Ye
Goyal, Ashima
Natwa, Mona
Hussein, Akram
Barr, Hallie
Konate, Dramane
Batdorf, Rochelle
Brown, Andrew
Williams, Bonnie
Zhao, Songzhu
Wei, Lai
Xu, Menglin
Shah, Manisha H.
Konda, Bhavana
PLOS ONE, 2024, 19 (05):
[25] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
Kwekkeboom, Dik J.
Krenning, Eric P.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
[26] Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
Bergsma, Hendrik
van Vliet, Esther I.
Teunissen, Jaap J. M.
Kam, Boen L. R.
de Herder, Wouter W.
Peeters, Robin P.
Krenning, Eric P.
Kwekkeboom, Dik J.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 867 - 881
[27] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
Singh, Abhay
Gravina, Matthew
Tajammal, Rutaba
Nowak, Annmarie
Iyer, Renuka
Faber, Mark G.
Yan, LunBiao
Hassane, Duane C.
Guzman, Monica L.
Mencia-Trinchant, Nuria
Wang, Eunice S.
Thota, Swapna
BLOOD, 2020, 136
[28] Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A two-year single institution experience
Duan, Heying
Ninatti, Gaia
Girod, Bradley
Ferri, Valentina
Guja, Kip
Song, Hong
Kunz, Pamela
Fisher, George
Iagaru, Andrei
Aparici, Carina Mari
JOURNAL OF NUCLEAR MEDICINE, 2020, 61
[29] Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
Marinova, Milka
Muecke, Martin
Fischer, Felix
Essler, Markus
Cuhls, Henning
Radbruch, Lukas
Ahmadzadehfar, Hojjat
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[30] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
Baum, Richard P.
Puranik, Ameya D.
Kulkarni, Harshad R.
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158

← 1 2 3 4 5 →